Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1996 Nov;89(3):368–374. doi: 10.1046/j.1365-2567.1996.d01-767.x

Saponin adjuvant primes for a dominant interleukin-10 production to ovalbumin and to Trypanosoma cruzi antigen.

C E Tadokoro 1, M S Macedo 1, I A Abrahamsohn 1
PMCID: PMC1456540  PMID: 8958049

Abstract

The adjuvant activity of saponin for T-cell responses was evaluated and compared with that of complete Freund's adjuvant (CFA) in two antigen systems: a lysate of the protozoa Trypanosoma cruzi and ovalbumin (OA). Strong delayed-type hypersensitivity and T-cell proliferate responses, comparable with those stimulated by CFA, were observed for both antigens following immunization with saponin as adjuvant. Upon in vitro secondary antigen stimulation, high interleukin-10 (IL-10) and low interferon-gamma (IFN-gamma) levels were observed in lymph node (LN) cell cultures from saponin-immunized mice in contrast with the high IFN-gamma and decreased IL-10 production by LN cells from CFA-immunized mice. Production of IL-10 and IFN-gamma in these conditions was CD4-activation dependent. Concanavalin A (Con A)-stimulated interleukin-4 (IL-4) production was higher in saponin-immunized mice than in CFA-immunized mice. IL-10 produced by LN cells from saponin-immunized mice suppressed IFN-gamma production and Con A-induced proliferation. Taken together, these data are consistent with in vivo stimulation of both T-helper (Th)1 and Th2-type cells by immunization with saponin; in vitro a Th2-type cytokine response with high IL-10 production predominates, indicating preferential priming towards a Th2-type response. Immunization with CFA induced a Th1-type cytokine response. To our knowledge this is the first report in which an adjuvant is shown to prime for a dominant IL-10 production.

Full text

PDF
368

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahamsohn I. A., Blotta M. H., Curotto M. A. Enhancement of delayed-type hypersensitivity to Trypanosoma cruzi in mice treated with Mycobacterium bovis BCG and cyclophosphamide. Infect Immun. 1981 Mar;31(3):1145–1151. doi: 10.1128/iai.31.3.1145-1151.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barbosa de Oliveira L. C., Curotto de Lafaille M. A., Collet de Araujo Lima G. M., de Almeida Abrahamsohn I. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection. Cell Immunol. 1996 May 25;170(1):41–53. doi: 10.1006/cimm.1996.0132. [DOI] [PubMed] [Google Scholar]
  3. Bomford R., McHardy N. Corynebacterium parvum as an adjuvant for Trypanosoma cruzi epimastigote vaccines: a comparison with saponin and Bordetella pertussis. Parasitology. 1979 Feb;78(1):77–87. doi: 10.1017/s0031182000048605. [DOI] [PubMed] [Google Scholar]
  4. Bomford R. Saponin and other haemolysins (vitamin A, aliphatic amines, polyene antibiotics) as adjuvants for SRBC in the mouse. Evidence for a role for cholesterol-binding in saponin adjuvanticity. Int Arch Allergy Appl Immunol. 1980;63(2):170–177. doi: 10.1159/000232623. [DOI] [PubMed] [Google Scholar]
  5. Bomford R., Stapleton M., Winsor S., McKnight A., Andronova T. The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants. AIDS Res Hum Retroviruses. 1992 Oct;8(10):1765–1771. doi: 10.1089/aid.1992.8.1765. [DOI] [PubMed] [Google Scholar]
  6. Bomford R. Studies on the cellular site of action of the adjuvant activity of saponin for sheep erythrocytes. Int Arch Allergy Appl Immunol. 1982;67(2):127–131. doi: 10.1159/000233002. [DOI] [PubMed] [Google Scholar]
  7. Curotto de Lafaille M. A., Barbosa de Oliveira L. C., Lima G. C., Abrahamsohn I. A. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. Exp Parasitol. 1990 Feb;70(2):164–174. doi: 10.1016/0014-4894(90)90097-v. [DOI] [PubMed] [Google Scholar]
  8. Dalsgaard K. Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines. Arch Gesamte Virusforsch. 1974;44(3):243–254. [PubMed] [Google Scholar]
  9. Ding L., Shevach E. M. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol. 1992 May 15;148(10):3133–3139. [PubMed] [Google Scholar]
  10. Emery D. L., Rothel J. S., Wood P. R. Influence of antigens and adjuvants on the production of gamma-interferon and antibody by ovine lymphocytes. Immunol Cell Biol. 1990 Apr;68(Pt 2):127–136. doi: 10.1038/icb.1990.18. [DOI] [PubMed] [Google Scholar]
  11. Flebbe L. M., Braley-Mullen H. Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens. Cell Immunol. 1986 Apr 15;99(1):119–127. doi: 10.1016/0008-8749(86)90221-2. [DOI] [PubMed] [Google Scholar]
  12. Fox B. S. Antibody responses to a cytochrome c peptide do not correlate with lymphokine production patterns from helper T-cell subsets. Immunology. 1992 Jan;75(1):164–169. [PMC free article] [PubMed] [Google Scholar]
  13. Gazzinelli R. T., Oswald I. P., Hieny S., James S. L., Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol. 1992 Oct;22(10):2501–2506. doi: 10.1002/eji.1830221006. [DOI] [PubMed] [Google Scholar]
  14. Grun J. L., Maurer P. H. Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. Cell Immunol. 1989 Jun;121(1):134–145. doi: 10.1016/0008-8749(89)90011-7. [DOI] [PubMed] [Google Scholar]
  15. Hörnquist E., Lycke N. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur J Immunol. 1993 Sep;23(9):2136–2143. doi: 10.1002/eji.1830230914. [DOI] [PubMed] [Google Scholar]
  16. Kenney J. S., Hughes B. W., Masada M. P., Allison A. C. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol Methods. 1989 Jul 26;121(2):157–166. doi: 10.1016/0022-1759(89)90156-7. [DOI] [PubMed] [Google Scholar]
  17. Kensil C. R., Patel U., Lennick M., Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J Immunol. 1991 Jan 15;146(2):431–437. [PubMed] [Google Scholar]
  18. Li L., Elliott J. F., Mosmann T. R. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol. 1994 Nov 1;153(9):3967–3978. [PubMed] [Google Scholar]
  19. Macatonia S. E., Doherty T. M., Knight S. C., O'Garra A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol. 1993 May 1;150(9):3755–3765. [PubMed] [Google Scholar]
  20. Marchal G., Seman M., Milon G., Truffa-Bachi P., Zilberfarb V. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J Immunol. 1982 Sep;129(3):954–958. [PubMed] [Google Scholar]
  21. McColm A. A., Bomford R., Dalton L. A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killed Plasmodium yoelii vaccine in the mouse. Parasite Immunol. 1982 Sep;4(5):337–347. doi: 10.1111/j.1365-3024.1982.tb00445.x. [DOI] [PubMed] [Google Scholar]
  22. Mosmann T. R. Properties and functions of interleukin-10. Adv Immunol. 1994;56:1–26. [PubMed] [Google Scholar]
  23. Newman M. J., Wu J. Y., Gardner B. H., Munroe K. J., Leombruno D., Recchia J., Kensil C. R., Coughlin R. T. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J Immunol. 1992 Apr 15;148(8):2357–2362. [PubMed] [Google Scholar]
  24. Powrie F., Menon S., Coffman R. L. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol. 1993 Sep;23(9):2223–2229. doi: 10.1002/eji.1830230926. [DOI] [PubMed] [Google Scholar]
  25. Scott M. T., Bahr G., Moddaber F., Afchain D., Chedid L. Adjuvant requirements for protective immunization of mice using a Trypanosoma cruzi 90K cell surface glycoprotein. Int Arch Allergy Appl Immunol. 1984;74(4):373–377. doi: 10.1159/000233576. [DOI] [PubMed] [Google Scholar]
  26. Silva J. S., Morrissey P. J., Grabstein K. H., Mohler K. M., Anderson D., Reed S. G. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med. 1992 Jan 1;175(1):169–174. doi: 10.1084/jem.175.1.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Titus R. G., Chiller J. M. A simple and effective method to assess murine delayed type hypersensitivity to proteins. J Immunol Methods. 1981;45(1):65–78. doi: 10.1016/0022-1759(81)90094-6. [DOI] [PubMed] [Google Scholar]
  28. Valensi J. P., Carlson J. R., Van Nest G. A. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J Immunol. 1994 Nov 1;153(9):4029–4039. [PubMed] [Google Scholar]
  29. Wu J. Y., Gardner B. H., Murphy C. I., Seals J. R., Kensil C. R., Recchia J., Beltz G. A., Newman G. W., Newman M. J. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J Immunol. 1992 Mar 1;148(5):1519–1525. [PubMed] [Google Scholar]
  30. Xu-Amano J., Kiyono H., Jackson R. J., Staats H. F., Fujihashi K., Burrows P. D., Elson C. O., Pillai S., McGhee J. R. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med. 1993 Oct 1;178(4):1309–1320. doi: 10.1084/jem.178.4.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES